Bioasis Technologies Inc. (BIOAF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | 37.72 Thousand | 4.07 Million | 606.38 Thousand | 1.42 Million | 589.84 Thousand |
| Cost of Revenue | - | 54.91 Thousand | 1.23 Million | - | 10.44 Thousand | 467.86 Thousand |
| Gross Profit | - | -17.19 Thousand | 2.84 Million | 606.38 Thousand | 1.41 Million | 121.97 Thousand |
| Operating Expenses | - | 3.63 Million | 3.69 Million | 5.2 Million | 6.26 Million | 5.39 Million |
| Selling, General and Administrative Expenses | - | 2.4 Million | 2.45 Million | 3.17 Million | 4.31 Million | 4.45 Million |
| Research and Development Expenses | - | 1.22 Million | 1.23 Million | 2.03 Million | 1.95 Million | 946.8 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | 3.63 Million | 3.69 Million | 5.2 Million | 6.27 Million | 5.86 Million |
| Operating Income | - | -4.88 Million | -83.3 Thousand | -5.19 Million | -6.23 Million | -5.23 Million |
| Interest Expense | - | 654.2 Thousand | - | 46.9 Thousand | - | - |
| Income Tax Expense | - | -636.68 Thousand | -318.32 Thousand | -545.26 Thousand | -1.38 Million | 30.68 Thousand |
| Earnings before Tax | - | -2.96 Million | 698.41 Thousand | -4.05 Million | -3.47 Million | -5.3 Million |
| Net Income | - | -2.96 Million | 698.41 Thousand | -4.05 Million | -3.47 Million | -5.3 Million |
| Earnings Per Share Basic | - | -0.04 | 0.01 | -0.07 | -0.06 | -0.10 |
| Earnings Per Share Diluted | - | -0.04 | 0.01 | -0.07 | -0.06 | -0.10 |
| Weighted Average Shares Outstanding | 78.21 Million | 72.16 Million | 68.11 Million | 62.27 Million | 56.67 Million | 50.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.21 Million | 72.16 Million | 68.11 Million | 62.27 Million | 56.67 Million | 50.9 Million |
| Gross Margin | - | -0.46 | 0.70 | 1.00 | 0.99 | 0.21 |
| EBIT Margin | - | -128.10 | -0.01 | -8.45 | -4.34 | -8.78 |
| Profit Margin | - | -78.46 | 0.17 | -6.69 | -2.44 | -9.00 |
| EBITDA | - | -3.54 Million | 438.16 Thousand | -4.53 Million | -4.78 Million | -5.22 Million |
| Earnings Before Tax Margin | - | -129.56 | -0.02 | -8.57 | -4.39 | -8.88 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 148.93 Thousand | 120.44 Thousand |
| Cost of Revenue | - | - | - | - | 220.85 Thousand | 31.32 Thousand |
| Gross Profit | - | - | - | - | -71.91 Thousand | 89.11 Thousand |
| Operating Expenses | - | - | - | - | 847.79 Thousand | 1.02 Million |
| Selling, General and Administrative Expenses | - | - | - | - | 626.94 Thousand | 774.27 Thousand |
| Research and Development Expenses | - | - | - | - | 220.85 Thousand | 245.82 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | - | - | - | - | 847.79 Thousand | 1.02 Million |
| Operating Income | - | - | - | - | -698.86 Thousand | -899.66 Thousand |
| Interest Expense | - | - | - | - | 212.02 Thousand | 230.29 Thousand |
| Income Tax Expense | - | - | - | - | 212.02 Thousand | 230.29 Thousand |
| Earnings before Tax | - | - | - | - | -985.67 Thousand | -1.09 Million |
| Net Income | - | - | - | - | -985.67 Thousand | -1.09 Million |
| Earnings Per Share Basic | - | - | - | - | -0.01 | -0.01 |
| Earnings Per Share Diluted | - | - | - | - | -0.01 | -0.01 |
| Weighted Average Shares Outstanding | - | - | - | 78.21 Million | 78.21 Million | 78.21 Million |
| Weighted Average Shares Outstanding (Diluted) | - | - | - | 78.21 Million | 78.21 Million | 78.21 Million |
| Gross Margin | - | - | - | - | -0.48 | 0.74 |
| EBIT Margin | - | - | - | - | -4.46 | -7.21 |
| Profit Margin | - | - | - | - | -6.62 | -9.05 |
| EBITDA | - | - | - | - | -664.02 Thousand | -868.33 Thousand |
| Earnings Before Tax Margin | - | - | - | - | -4.69 | -7.47 |
XOM
CEGMF
010120
9271
MPOW
AMPY